Lack of complement factor C3, but not factor B, increases hyperlipidemia and atherosclerosis in apolipoprotein E-/- low-density lipoprotein receptor-/- mice

被引:85
|
作者
Persson, L
Borén, J
Robertson, AKL
Wallenius, V
Hansson, GK
Pekna, M
机构
[1] Univ Gothenburg, Sahlgrenska Acad, Dept Med Biochem, S-40530 Gothenburg, Sweden
[2] Univ Gothenburg, Sahlgrenska Acad, Wallenberg Lab Cardiovasc Res, S-40530 Gothenburg, Sweden
[3] Univ Gothenburg, Sahlgrenska Acad, Res Ctr Endocrinol & Metab, S-40530 Gothenburg, Sweden
[4] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden
关键词
atherosclerosis; complement; C3; factor B; hyperlipidemia;
D O I
10.1161/01.ATV.0000127302.24266.40
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective - To investigate the effect of complement deficiency on atherogenesis and lipidemia, we used mice deficient in the third complement component (C3-/-) or factor B (FB-/-). Methods and Results - Complement-deficient mice were crossed with mice deficient in both apolipoprotein E and the low-density lipoprotein receptor (Apoe-/- LDLR-/-). The percent lesion area in the aorta at 16 weeks, determined by en face analysis, was 84% higher in C3-/- mice than in controls (11.8% +/- 0.4% versus 6.4% +/- 0.8%, mean +/- SEM, P < 0.00005). The C3-/- mice also had 58% higher serum triglyceride levels (P < 0.05) and a more proatherogenic lipoprotein profile, with significantly more low-density lipoprotein cholesterol and very-low-density lipoprotein triglycerides than control mice. The C3-/- mice weighed 13% less (P < 0.01) and had a lower body fat content (3.5% +/- 1.0% versus 13.1% +/- 3.0%, P < 0.01). There were no differences between FB-/- mice and controls. Conclusions - Complement activation by the classical or lectin pathway exerts atheroprotective effects, possibly through the regulation of lipid metabolism.
引用
收藏
页码:1062 / 1067
页数:6
相关论文
共 50 条
  • [1] Immunoglobulin treatment reduces atherosclerosis in apolipoprotein E-/- low-density lipoprotein receptor -/- mice via the complement system
    Persson, L
    Borén, J
    Nicoletti, A
    Hansson, GK
    Pekna, M
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2005, 142 (03): : 441 - 445
  • [2] Decay-Accelerating Factor Suppresses Complement C3 Activation and Retards Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice
    Leung, Viola W. Y.
    Yun, Sheng
    Botto, Marina
    Mason, Justin C.
    Malik, Talat H.
    Song, Wenchao
    Paixao-Cavalcante, Danielle
    Pickering, Matthew C.
    Boyle, Joseph J.
    Haskard, Dorian O.
    AMERICAN JOURNAL OF PATHOLOGY, 2009, 175 (04): : 1757 - 1767
  • [3] Cyclooxygenase-1 deficiency in bone marrow cells increases early atherosclerosis in apolipoprotein E- and low-density lipoprotein receptor-null mice
    Babaev, VR
    Ding, L
    Reese, J
    Morrow, JD
    Breyer, MD
    Dey, SK
    Fazio, S
    Linton, MF
    CIRCULATION, 2006, 113 (01) : 108 - 117
  • [4] Lecithin:cholesterol acyltransferase deficiency increases atherosclerosis in the low density lipoprotein receptor and apolipoprotein E knockout mice
    Furbee, JW
    Sawyer, JK
    Parks, JS
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (05) : 3511 - 3519
  • [5] Severe Hyperglycemia, Hyperlipidemia, and Atherosclerosis in Akita Diabetic Mice Lacking the Low-Density Lipoprotein Receptor
    Zhou, Changcheng
    Pridgen, Brian
    King, Nakesha
    Breslow, Jan L.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (11) : E245 - E245
  • [6] Modulation of lectin-like oxidized low-density lipoprotein receptor-1 by Porphyromonas gingivalis promoting progression of atherosclerosis in apolipoprotein E-/- mice
    Zhang, Shengnan
    Liu, Jianru
    Ouyang, Xiangying
    Lyu, Peiying
    Wang, Yuanbo
    Zhong, Jinsheng
    JOURNAL OF DENTAL SCIENCES, 2025, 20 (02) : 754 - 763
  • [7] Adipose tissue deficiency results in severe hyperlipidemia and atherosclerosis in the low-density lipoprotein receptor knockout mice
    Wang, Mengyu
    Gao, Mingming
    Liao, Jiawei
    Qi, Yanfei
    Du, Ximing
    Wang, Yuhui
    Li, Ling
    Liu, George
    Yang, Hongyuan
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2016, 1861 (05): : 410 - 418
  • [8] Recombinant antibodies to an oxidized low-density lipoprotein epitope induce rapid regression of atherosclerosis in Apobec-1-/-/low-density lipoprotein receptor-/- mice
    Schiopu, Alexandru
    Frendeus, Bjoern
    Jansson, Bo
    Soederberg, Ingrid
    Ljungcrantz, Irena
    Araya, Zufan
    Shah, Predinian K.
    Carlsson, Roland
    Nilsson, Jan
    Fredrikson, Gunilla Nordin
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (24) : 2313 - 2318
  • [9] Macrophage migration inhibitory factor deficiency impairs atherosclerosis in low-density lipoprotein receptor-deficient mice
    Pan, JH
    Sukhova, GK
    Yang, JT
    Wang, B
    Xie, T
    Fu, HX
    Zhang, X
    Satoskar, AR
    David, JR
    Metz, CN
    Bucala, R
    Fang, K
    Simon, DI
    Chapman, HA
    Libby, P
    Shi, GP
    CIRCULATION, 2004, 109 (25) : 3149 - 3153
  • [10] Complement C1q reduces early atherosclerosis in low-density lipoprotein receptor-deficient mice
    Bhatia, Vinay K.
    Yun, Sheng
    Leung, Viola
    Grimsditch, David C.
    Benson, G. Martin
    Botto, Marina B.
    Boyle, Joseph J.
    Haskard, Dorian O.
    AMERICAN JOURNAL OF PATHOLOGY, 2007, 170 (01): : 416 - 426